Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

229 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL

NCT04030195

Conditions
B-cell Chronic Lymphocytic Leukemia, B-cell Non Hodgkin Lymphoma, Chronic Disease, +25 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University Stanford, California, United States
  • Columbia University New York, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)

NCT00912223

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego (UCSD) Medical Center La Jolla, California, United States
  • University of California, Davis Medical Center Sacramento, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
View all 21 locations
View Trial Details
Completed

Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab

NCT02747043

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Research Site Encinitas, California, United States
  • Research Site Mount Sterling, Kentucky, United States
  • Research Site Billings, Montana, United States
  • Research Site Zanesville, Ohio, United States
View all 98 locations
View Trial Details
Completed

Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma

NCT03682796

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of CC-95775 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma

NCT04089527

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Institut Curie Paris, France
  • Hopital Saint Louis Paris, France
  • Centre Eugene Marquis Rennes, France
  • Hospital de Madrid Norte- Sanchinarro Madrid, Spain
View Trial Details
Completed

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

NCT00000658

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations
  • USC CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
View all 22 locations
View Trial Details

Related conditions